AmpliPhi Bioscience Corporation

AmpliPhi Biosciences (US: APHB) is a biopharmaceutical company focused on the development of an internally generated pipeline of naturally occurring viruses called bacteriophage (phage) for the treatment of bacterial infection.  Phage-based therapy provides a unique and proven approach to treating a wide variety of bacterial infections and in particular, drug-resistant strains of bacteria that are commonly found in the hospital setting.  The Company has built a drug development and manufacturing platform designed to allow rapid development and production of multiple phage-based therapies. 

To learn more, visit www.ampliphibio.com